from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1890c/-

LFCtreatmentdescriptionclass of inhibitor

-0.691

Amikacinug/mL Amikacintranslation

0.922

Cap5-10ug/mL Capreomycintranslation

0.713

Rox10-50 ug/mL Roxithromycintranslation

-1.305

SM2-5 ug/mL Streptomycintranslation

0.084

Tet5-10 ug/mL Tetracyclinetranslation

0.538

Rif0.2-5ug/mL Rifampicintranscription

0.573

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.484

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.739

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.373

CPZ10-50 ug/mL Chlorpromazinerespiration

1.229

Clofazimine10-13 ug/mL Clofaziminerespiration

0.198

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.732

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.561

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.507

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.975

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.192

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.847

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.770

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.400

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.126

KCN5-20 ug/mL Potassium cyaniderespiration

0.454

NaN30.2-2 mM Sodium aziderespiration

-0.238

Nigericin50 uM Nigericinrespiration

0.104

TRC10-150 ug/mL Triclosanrespiration

1.924

TRZ10-25 ug/mL Thioridazinerespiration

0.868

Valinomycin0.5-10 uM Valinomycinrespiration

-1.925

ZnSO42 mM ZnSO4respiration

0.431

menadione6-10 ug/mL Menadionerespiration

0.690

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.750

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.545

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.465

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.587

NRP_1Non-replicating persistence stage 1dosRassociated

-1.198

Amp0.2mg/mL AmpicillincellWall

-0.174

Cephalexin20-100 ug/mL CephalexincellWall

-0.279

Cerulenin0.32-5 ug/mL CerulenincellWall

-1.025

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.324

EMB10-20 ug/mL EthambutolcellWall

-1.270

Eta12-40 ug/mL EthionamidecellWall

-1.498

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.582

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.333

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.016

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.542

BZA0.12 mg/mL BenzamidearomaticAmides

-0.482

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.420

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.381

H2O24 mM hydrogen peroxideDNAdamaging

0.331

Levo10 ug/mL LevofloxacinDNAdamaging

-0.904

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.918

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.950

Oflox5-10 ug/mL OfloxacinDNAdamaging

-1.379

UVUV-irradiationDNAdamaging

2.108

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.116

Antimycin12.5-50 ug/mL Antimycin A?

0.314

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.135

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.178

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.911

PA8240.2-2 ug/mL PA-824?

-0.182

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.092

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.400

Verapamil50 uM Verapamil?

0.603

mercaptoethanol2 mM 2-Mercaptoethanol?

0.047

methoxatin10-20 ug/mL Methoxatin?